Option Care Health Inc (OPCH) shares plunged 9.80% in pre-market trading on Thursday, following the release of its third-quarter 2025 earnings report. The significant drop comes despite the company beating analyst expectations for the quarter, suggesting that investors were more focused on the company's full-year guidance.

For the third quarter ended September 30, 2025, Option Care Health reported impressive results. Revenue came in at $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. The company's adjusted earnings per share (EPS) of $0.45 also beat the estimated $0.42, while adjusted EBITDA reached $119.5 million, exceeding expectations of $118.4 million.

However, the company's outlook for the full year 2025 appears to have disappointed investors. Option Care Health now expects net revenue between $5.60 billion and $5.65 billion, and adjusted EPS of $1.68 to $1.72. While these figures are in line with current FactSet estimates, they may not have been strong enough to justify the stock's recent valuation. Additionally, the projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic expectations, contributing to the negative sentiment in pre-market trading.

The sharp decline in Option Care Health's stock price, despite its strong quarterly performance, highlights the importance of forward-looking guidance in shaping investor sentiment. As the healthcare facilities and services sector continues to navigate a dynamic regulatory environment, companies like Option Care Health face increasing pressure to not only deliver strong current results but also to provide compelling future outlooks to maintain investor confidence.